Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Aurora enters screening agreement with Roche

Feb. 26, 1999

Biogen and Ontogeny extend hedgehog protein collaboration

Feb. 26, 1999

Merck terminates negotiations with Bioject

Feb. 26, 1999

Aurora enters assay development and screening agreement with P&U

Feb. 25, 1999

Protein Sciences, Texas A&M combine intellectual property positions on BEVS

Feb. 24, 1999

Anesta enters agreement with Novartis for transmucosal drug delivery

Feb. 24, 1999

DiagnoCure plans preclinical trials of its patented vectors in melanoma

Feb. 24, 1999

Trimera mouse model for human HBV described

Feb. 23, 1999

Xenometrix grants gene expression profiling patent license to Genzyme

Feb. 23, 1999

U.S. patent providing improved gene delivery vectors issued to GenVec

Feb. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...